TonB protein appears to couple the electrochemical potential of the cytoplasmic membrane to active transport across the essentially unenergized outer membrane of gram-negative bacteria. ExbB protein has been identified as an auxiliary protein in this process. In this paper we show that ExbD protein, encoded by an adjacent gene in the exb cluster at 65, was also required for TonB-dependent energy transduction and, like ExbB, was required for the stability of TonB. The phenotypes of exbB exbD ؉ strains were essentially indistinguishable from the phenotypes of exbB ؉ exbD strains. Mutations in either gene resulted in the degradation of TonB protein and in decreased, but not entirely absent, sensitivities to colicins B and Ia and to bacteriophage 80. Evidence that the absence of ExbB or ExbD differentially affected the half-lives of newly synthesized and steady-state TonB was obtained. In the absence of ExbB or ExbD, newly synthesized TonB was degraded with a half-life of 5 to 10 min, while the half-life of TonB under steady-state conditions was significantly longer, approximately 30 min. These results were consistent with the idea that ExbB and ExbD play roles in the assembly of TonB into an energy-transducing complex. While interaction between TonB and ExbD was suggested by the effect of ExbD on TonB stability, interaction of ExbD with TonB was detected by neither in vivo cross-linking assays nor genetic tests for competition. Assays of a chromosomally encoded exbD::phoA fusion showed that exbB and exbD were transcribed as an operon, such that ExbD-PhoA levels in an exbB::Tn10 strain were reduced to 4% of the levels observed in an exbB ؉ strain under iron-limiting conditions. Residual ExbD-PhoA expression in an exbB::Tn10 strain was not iron regulated and may have originated from within the Tn10 element in exbB.
The acquisition of Fe(III) siderophores and vitamin B 12 by gram-negative bacteria appears to be energized by the transduction of the cytoplasmic membrane proton motive force to a set of outer membrane proteins (termed receptors) that actively transport those nutrients into the periplasmic space. In this process, the cytoplasmic membrane protein, TonB, serves as the energy transducer (1) . An auxiliary cytoplasmic membrane protein, ExbB, is required for the stability of TonB (9, 33) and plays a direct role in energy transduction (20, 32) .
ExbB is encoded by the first of a closely positioned pair of genes, with the second gene encoding ExbD (8) . ExbB is a 26-kDa protein that traverses the cytoplasmic membrane three times, with the majority of the protein occupying the cytoplasm (9, 16, 17) . ExbD, a 17.8-kDa cytoplasmic membrane protein, has a single transmembrane region at its amino terminus, with the majority of the protein extending into the periplasmic space (15) . On the basis of this topological partitioning, it has been proposed that the two proteins may function in concert as a signal transduction molecule (26) .
The process of transcriptional regulation of the two proteins is not clear. Since the open reading frames encoding these proteins are separated by only 9 bp, it has been suggested that the genes are coordinately expressed as an operon. Alternatively, the presence of potential promoter and Fur repressor binding sites just 5Ј to the putative initiation codon of exbD has led to the suggestion that exbB and exbD could be independently expressed (8) . The most likely scenario is that the two genes are cotranscribed. The issue becomes whether exbD is expressed independently from its own promoter in addition to the cotranscription.
Determining the site that regulates exbD expression is important, since most studies to date have used either exb deletion mutants or a mutant resulting from a Tn10 insertion in the 5Ј end of exbB. If exbB and exbD are transcribed as an operon, then such mutations could not distinguish the relative contributions of each protein to the energy transduction process, because of the polarity of exbB::Tn10 on exbD expression.
In this study, we show that ExbD is expressed primarily, if not entirely, through transcription initiation at the exbB promoter. The phenotypes of strains singly lacking either intact exbB or exbD are indistinguishable, indicating that the roles these proteins play in TonB-dependent phenomena are interdependent. In addition, we present evidence that the absence of ExbB or ExbD differentially affects the half-lives of newly synthesized and steady-state TonB.
MATERIALS AND METHODS
Bacteria, plasmids, bacteriophages, and media. The bacteria and plasmids used in this study are listed in Table 1 . The bacteria are all derivatives of Escherichia coli K-12. P1vir (25) was used for transductions, and 80vir was used for TonB activity assays (23) . Chemicals were purchased from Sigma except as indicated. Tryptone (T)-plates, tryptone top (T-top) agar, Luria-Bertani (LB) medium, and M9 salts were as described previously (25) , except that T-plates and T-top agar were supplemented with 5 mM CaCl 2 . M9 minimal medium was prepared as described previously, containing either defined amino acids or Casamino Acids purchased from Difco (33) . Antibiotics were used at the following concentrations: chloramphenicol at 50 g/ml for plasmid maintenance and 100 g/ml for chemical stability studies, kanamycin at 20 g/ml, and tetracycline at 20 g/ml. 5-Bromo-4-chloro-3-indolyl phosphate (XP) was used at 40 g/ml. 2,2Ј-Dipyridyl was used at 200 M. FeCl 3 was used at 90 M. Colicins were prepared as previously described (20) . Oligonucleotides were synthesized by Midland Certified Reagent Co. and by the Bioanalytical Laboratory at Washington State University.
Strain constructions. TnphoA insertions in MC4100 were generated by TnphoA mutagenesis as described previously (11) . Insertion mutants were selected on LB plates containing kanamycin and XP and onto which 100 l of a 10 Ϫ4 dilution of a crude colicin B preparation was applied. This level of colicin B was sufficient to kill MC4100 but not an MC4100 exbB::Tn10 strain (data not shown). Colonies that were blue, suggesting an in-frame, periplasmically localized PhoA fusion protein, were screened further. Isolates resulting from mutations in either tonB or fepA were identified by being either resistant to both undiluted colicin B and 80 (tonB) or resistant only to undiluted colicin B (fepA) and were not considered further. A single TnphoA insertion, resulting from the mutagenesis and screening and called KP1140, was selected for further study.
Strains KP1141, KP1142, KP1143, and KP1089 were constructed by P1 transduction of the TnphoA from KP1140 into MC4100, MO, W3110, and GM1, respectively, with selection for kanamycin resistance. Strain KP1036 was constructed by transduction of exbB::Tn10 from H1388 (13) into W3110, selecting for tetracycline resistance, and screening for degree of colicin B tolerance. Strain KP1118 was constructed by transduction of TnphoA from KP1140 into KP1036 (exbB::Tn10), selecting for kanamycin and tetracycline resistance, and confirming by subsequent linkage analysis. Strain KP1133 was constructed by transduction of TnphoA from KP1140 into KP1082 [⌬(ana-tonB-trp)] and selecting for kanamycin resistance. KP1133 was confirmed to be tolerant to 80 and capable of hydrolyzing XP and, by immunoblot analysis, was shown to lack TonB but to encode the correct ExbD-PhoA fusion protein. Strain KP1184 was constructed by transduction of recA linked to srl::Tn10 from JC10241 (7) into KP1143, selecting for tetracycline resistance, and screening for sensitivity to short-wavelength UV light. Strain KP1229 was constructed by transduction of the ⌬(anatonB-trp) deletion from CH483 into W3110, selecting for simultaneous resistance to 80 and colicin B, and screening for the ana and trp phenotypes. The presence of the deletion was ultimately confirmed by PCR analysis.
Linkage mapping of exbD::TnphoA. The TnphoA in KP1142 was mapped by Hfr and P1 techniques as described previously (25) with the mapping strain collection of Singer et al. (31) .
Plasmid constructions. Plasmid pKP298, carrying both exbB and exbD, was constructed by cloning the 1,929-bp SspI fragment from pLC4-14 (6) into the EcoRV site of pACYC184. Plasmid pKP311, carrying the exbD gene alone, was constructed by using synthetic oligonucleotides corresponding to bases 1239 to 1259 (oKP146) and 1728 to 1748 (oKP135) of the published exbBD DNA sequence (8) in conjunction with Vent R DNA polymerase (New England Biolabs), to amplify the exbD gene from W3110 DNA by PCR. Oligonucleotide oKP135 also contained six noncomplementary nucleotides, corresponding to an EcoRI linker at the 5Ј end. The PCR product was directly cloned into the EcoRV site of pZ150 (36) , with selection for ampicillin resistance and screening for tetracycline sensitivity. Orientation was determined by restriction with EcoRI, and a clone with exbD in the same orientation as the tet gene was chosen for further study (pKP311). This plasmid carries no exbD-specific sequences downstream from the TAA stop codon of exbD.
Plasmid pKP308, carrying the TnphoA from KP1142, was constructed by mini-Mu cloning (10) . Briefly, KP1142 was first lysogenized with Mu cts62 and then transformed with the mini-Mu vector pBC4042. A Mu lysate made from this strain was used to infect W3110 lysogenized with Mu cts62. The infected cells were plated on LB plates containing chloramphenicol, kanamycin, and XP to select and identify TnphoA-containing plasmids. One of the resulting plasmids was purified and used for further analysis.
DNA sequence analysis. The exbD::TnphoA fusion junction in pKP308 was sequenced by double-stranded dideoxy sequencing as described previously (30) , with reagents from United States Biochemical and ␥- (22), was used to prime the reactions.
Colicin and 80 sensitivity assays. Bacteria were grown in LB to an A 550 of 0.5 (path length, 1.5 cm; measured with a Spectronic 20 spectrophotometer). Cells (200 l) were plated on T-plates after suspension in 3 ml of molten T-top agar (25) . After the T-top agar had hardened, dilution series of colicin B, Ia, or E1 or bacteriophage 80 were spotted on the T-plates as 10-l aliquots. Plates were examined following overnight incubation at 37ЊC and were scored as indicated in individual figure legends. Where indicated, antibiotics were included in both the T-plates and the T-top agar.
Irreversible 80 adsorption was assayed essentially as described previously (21) . Briefly, cells were cultured in 5 ml of M9 minimal medium (supplemented with defined amino acids) to an A 550 of 0.5, centrifuged, and suspended in 125 l of 5 mM CaCl 2 containing 80 at a multiplicity of infection (MOI) of 1.0. Samples of 10 l were removed at 0, 5, 10, and 20 min and placed in 1 ml of LB containing 5 l of CHCl 3 and were vortexed and titered to determine the fraction of unadsorbed 80.
Chemical half-life determinations for steady-state TonB. Chemical half-lives for steady-state TonB were determined as follows. Cultures were grown to an A 600 of 0.5 in LB, a sample was removed (at time zero), and chloramphenicol was added (final concentration, 100 g/ml) to the remainder to stop protein synthesis. Equivalent samples were then removed 30, 60, and 120 min later. All samples were immediately precipitated with trichloroacetic acid (TCA) and suspended in Laemmli sample buffer (19) . Samples were electrophoresed on sodium dodecyl sulfate (SDS)-11% polyacrylamide gels and electrotransferred to Immobilon P membranes (Millipore). TonB was detected by immunoblotting with anti-TonB monoclonal antibody 4H4 (32), while ExbD-PhoA fusion protein was detected by immunoblotting with anti-alkaline phosphatase antibody (5Ј-3Ј Inc.). Relative protein levels were quantitated with a Pharmacia LKB Imagemaster densitometer and normalized to the A 600 of individual cell cultures. Half-lives were calculated from the 0-and 30-min time points by the standard equation for a first-order decay process.
Chemical half-life determinations for newly synthesized TonB. Immunoprecipitation of TonB protein was performed by a modification of a previously described technique (28, 33) . Briefly, cells were grown to an A 550 of 0.4 in 5 ml of M9 medium (supplemented with 0.2% glucose, 0.4 g of thiamine per ml, 0.1 mM MgSO 4 , 0.5 mM CaCl 2 , and a defined amino acid mix lacking methionine [amino acids at 40 g/ml, except Tyr, which was at 0.4 g/ml, and Asp and Glu, which were at 30 g/ml]) and treated for 1 min with [ 35 S]methionine (300 Ci at 1,187 Ci/mM), and then a 600-fold molar excess of unlabelled methionine and 100 g of chloramphenicol per ml were added. Aliquots of 1 ml were harvested at 0, 5, 15, 30, and 60 min following the addition of unlabelled methionine and then were immediately mixed with 2 ml of prechilled (4ЊC) 20% TCA, stored on ice 15 min, pelleted, rinsed once in 50 mM Tris-Cl (pH 8.0), suspended in 50 l of Laemmli sample buffer, and boiled for 5 min. Samples were then diluted in 1 ml of radioimmunoprecipitation assay buffer (28) and centrifuged at 40,000 ϫ g for 30 min, and the supernatant was incubated for 1 h at 4ЊC with 5 l of monoclonal antibody 4H4 ascites. Supernatants were then incubated for 1 h with 200 l of recombinant protein G agarose (Gibco BRL) that had been previously washed with and suspended as a 1:1 slurry in unlabelled KP1229 (⌬tonB) lysate and then were washed five times with radioimmunoprecipitation assay buffer and twice with 10 mM Tris-Cl (pH 8.0)-50 mM NaCl. The final pellet was solubilized in 25 l of Laemmli sample buffer and resolved on SDS-11% polyacrylamide gels. Following electrophoresis, gels were treated with Entensify autofluor (DuPont NEN), dried, and exposed to Kodak XAR5 film for 18 h at Ϫ70ЊC.
In vivo chemical cross-linking. In vivo chemical cross-linking with formaldehyde was performed as described previously (32) , except that samples were solubilized at 60ЊC rather than at 37ЊC.
Alkaline phosphatase activity assays. Alkaline phosphatase assays were performed as described previously (24) 
RESULTS
Isolation of exbD::TnphoA mutation. To study exbD function and regulation, we isolated an exbD::TnphoA mutation by mutagenesis with TnphoA, selecting for kanamycin resistance and tolerance to a low level of colicin B. The isolate KP1140 remained sensitive to 80 and to undiluted colicin B, indicating that it was neither a tonB nor a fepA mutant. This phenotype was maintained following P1 transduction of the TnphoA from KP1140 into MC4100, MO, W3110, and GM1, indicating that secondary mutations did not contribute to the observed phenotype.
Results from Hfr and P1 mapping indicated that TnphoA was 99% linked to metC, suggesting the possibility that it had transposed within the neighboring exb locus. To determine the precise location, the chromosomal region surrounding TnphoA was cloned with the mini-Mu plasmid pBC4042 (10) . Sequence analysis of the resulting plasmid, pKP308, indicated that TnphoA was inserted at bp 1687 of the published sequence (8), fusing alkaline phosphatase to threonine 121 of ExbD (data not shown).
exbD phenotype. The exb locus contains two genes, exbB followed by exbD. A variety of exb insertion mutations have similar TonB-leaky phenotypes, consisting of reduced colicin and bacteriophage sensitivity and reduced siderophore and vitamin B 12 transport. One widely used mutation is a Tn10 insertion located at the 5Ј end of exbB (13) . To date it is not clear whether the exb phenotype is due to loss of ExbB, loss of ExbD, or loss of both. Furthermore, the phenotype of an exbD mutant has not been reported.
To determine the phenotype of an exbD mutation, we compared the sensitivities of W3110 and its isogenic derivatives KP1036 (exbB::Tn10), KP1143 (exbD::TnphoA), and KP1118 (exbB::Tn10 exbD::TnphoA) to colicins B, Ia, and E1 and bacteriophage 80 (Table 2) . We also compared the strains by means of the more sensitive assay of 80 adsorption (Fig. 1) . The three mutant strains, while more resistant than the W3110 parent, were indistinguishable from one another as judged by the assays performed.
The mutant strains also had similar effects on TonB stability (Fig. 2) . TonB was stable in W3110 (half-life, Ͼ1 h) and unstable in the exbB::Tn10 background (KP1036; half-life, ϳ30 min). TonB was also unstable to a similar degree in the exbD:: TnphoA background (KP1143; half-life, ϳ40 min). Although in Fig. 2 the half-life of TonB in the exbD background appears to be somewhat longer than that in the exbB::Tn10 strain, this is, as determined by densitometer scans, an illusion, reflecting the unexplained increase in steady-state levels of TonB in this strain. The half-lives observed in this study for steady-state TonB were significantly longer than those previously observed (33); the discrepancy is addressed later in this report. The   FIG. 1 . Effects of exb mutations on irreversible 80 adsorption. Assays were performed as described in Materials and Methods. Each point represents the mean of three assays. The higher the fraction unadsorbed is, the greater the negative effect of the mutation is. å, KP1118(pKP311); ᮀ, KP1143(pKP311); F, KP1036; E, KP1143; s, W3110. a TonB function was assayed by sensitivity to the TonB-dependent colicins B and Ia and phage 80. All strains were equally sensitive to colicin E1, a TonBindependent colicin (data not shown). The indicated colicin or bacteriophage (10 l) was spotted on the indicated strains, which were suspended in T-top agar, and the resulting plates were incubated at 37ЊC. The results for colicins indicate the final 5-fold dilution that resulted in complete clearing of the indicator strain. The results for phage 80 indicate the first 10-fold dilution that resulted in no plaques being formed on the indicator strain. In all cases, higher numbers indicate higher levels of TonB function. All assays were performed in triplicate and gave identical results. r, resistance to undiluted colicin or phage.
FIG. 2. Effects of exb mutations on
instability of TonB in the exbD::TnphoA strain suggested that the two proteins might interact, as has been observed for TonB-ExbB. For unknown reasons, TonB appeared to be slightly more stable in the exbB::Tn10 exbD::TnphoA strain.
Several further tests for detecting interaction between ExbD and TonB were performed. These included an attempt to cross-link TonB and ExbD-PhoA, the determination of the ExbD-PhoA half-life in the absence of TonB, and a genetic assay for possible codominance of exbD::phoA with exbD. All such further tests gave negative results. exbB phenotype. ExbB protein can be cross-linked to TonB in vivo (20, 32) . While it is then reasonable to presume that the loss of ExbB specifically affects TonB activity and stability, the formal possibility that the exbB::Tn10 phenotype derives solely from the loss of ExbD could not be excluded. To determine the phenotype of an exbB mutation in an exbD ϩ background, the exbD gene was cloned on a multicopy plasmid and added in trans to exbD::TnphoA and exbB::Tn10 exbD::TnphoA strains and assayed for colicin and 80 sensitivities ( Table 2 and Fig.  1 ). The exbD plasmid restored full function to the exbD:: TnphoA mutant, KP1143, confirming that the plasmid expressed ExbD. Identical results were obtained for a recA derivative of KP1143 (KP1184), indicating that results were not due to homologous recombination (data not shown). The phenotype of the exbB::Tn10 exbD::TnphoA strain complemented with the exbD plasmid was identical to that of the exbD:: TnphoA strain with respect to 80, colicin B, and colicin Ia sensitivities (Table 2 ) and similar regarding the short half-life of TonB (Fig. 2) , suggesting that the loss of ExbB affected TonB activity similarly to the loss of ExbD.
ExbD is expressed primarily from the exbB promoter. Two approaches were taken to estimate the relative extents of exbD expression arising from the exbB promoter and the putative exbD promoter. First, effects of an exbB::Tn10 insertion on exbD::TnphoA expression were assayed by measuring alkaline phosphatase activity (Table 3) . In these experiments, exbD:: TnphoA expression could be induced to 30 U of activity in the absence of iron. In the presence of iron, expression was threefold repressible aerobically and at least 10-fold repressible anaerobically. This regulatory pattern was similar to those of both exbB and tonB (2, 35) . The presence of an upstream Tn10 insertion in exbB reduced phoA activity to the iron-insensitive background levels produced by the repressed endogenous phoA genes of W3110 and KP1036, suggesting the absence of an independent exbD promoter.
Second, in a more sensitive assay, levels of ExbD-PhoA protein expressed from exbB ϩ and exbB::Tn10 strains were compared by immunoblot analysis of a culture dilution series (data not shown). Relative levels of ExbD-PhoA were quantitated by densitometer scanning of dilutions across the linear range of film sensitivity and were normalized with respect to dilution factors and A 550 s of the individual cultures. These results confirmed that the putative exbD promoter was essentially inactive. The residual activity, which was 4% of the exbB ϩ value under inducing conditions (19% of the exbB ϩ value under repressing conditions), could have arisen from either the putative exbD promoter or Tn10 itself (18) .
In the absence of ExbB or ExbD, newly synthesized TonB is more rapidly degraded than steady-state TonB. We noticed a significant discrepancy between the previously reported halflives of newly synthesized TonB in the absence of ExbB (ϳ5 min, as assayed by pulse-labelling and immunoprecipitation [33] ) and the results of this study on half-lives of steady-state TonB in the absence of ExbB (ϳ30 to 40 min, as assayed by chloramphenicol treatment, TCA precipitation, and immunoblot) (Fig. 2) . To exclude the possibility that the discrepancy was due to not using TCA precipitation preceding the original immunoprecipitations, we repeated those early experiments, this time following the labelling with immediate TCA precipitation. In addition, we used the same monoclonal antibody used for immunoblot analysis of TonB (Fig. 2) . The results obtained confirmed our earlier observations that the absence of ExbB results in a half-life of ϳ5 min for newly synthesized TonB (Fig. 3) . Consistent with the longer steady-state half-life 35 S]methionine-labelled TonB was immunoprecipitated from strains of interest at 0 to 60 min following the addition of unlabelled methionine as described in Materials and Methods and then was resolved on SDS-11% polyacrylamide gels and visualized by autoradiography. Additional samples were identically prepared from KP1229, from which the tonB gene had been deleted (lanes ⌬). Each panel presents the gel region from 22 to 50 kDa, with apparent molecular masses represented by 14 C-labelled markers (lanes St) and indicated (in kilodaltons) by the arrows to the right of the panels. Relevant genotypes of the strains (identical to those in Fig. 1 ) and time points (in minutes) for samples are indicated above the panels. 
DISCUSSION
While it seems clear that TonB plays a central role in energy transduction, the roles of the auxiliary proteins ExbB and ExbD have been less clear. Some clarity was achieved with the discovery that the leaky effect of exb mutations was due to the existence of homologous proteins, TolQ and TolR, which can substitute to a small but significant degree for the lack of ExbB and ExbD (3). Overexpressed ExbB can stabilize overexpressed TonB (9) . In addition, it has been shown that a Tn10 insertion early in exbB (13) results in decreased stability of chromosomally encoded TonB (33) and decreased energy transduction, even when wild-type levels of TonB are present (32) .
However, the individual roles of the two proteins have not been resolved, in part because the interdependence of their expression has not been determined. It was previously suggested that the exbB::Tn10 used in most studies is polar to some extent on exbD expression (8) . However in subsequent studies, it was assumed that the exbD gene could be expressed independently when cloned in the opposite orientation to the lac operon promoter and used for complementation experiments (4). In addition, a putative promoter upstream of exbD was postulated on the basis of sequence analysis (8) . Thus, the degree of exbD expression in the exbB::Tn10 mutant has been unclear. Furthermore, the phenotype of an exbD mutant and the contributions of exbB and exbD to the classical exb phenotype had not been determined.
We isolated and characterized a chromosomally encoded exbD::TnphoA mutation, in which the fusion junction occurred at amino acid 121, leaving most (86%) of ExbD intact. This mutant had the same decreased level of TonB activity as the exbB::Tn10 mutant and an exbB::Tn10 exbD::TnphoA double mutant, as assayed by sensitivity to colicins B and Ia and bacteriophage 80. In addition, mutations in all three strains resulted in a decrease in steady-state TonB chemical stability, from Ͼ2 h in the wild type to approximately 30 to 40 min in the exb strains. Previous studies of overexpressed ExbB, ExbD, and TonB had suggested that overexpressed ExbB, but not ExbD, could stabilize overexpressed TonB (9). It is not clear why no requirement for ExbD in stabilizing TonB was observed in this study. Perhaps ExbB (which was not overexpressed in previous studies. was required to form the complex that would allow ExbD to interact and stabilize TonB. Thus ExbD could be necessary but not sufficient to stabilize TonB.
We have previously reported the chemical half-life of TonB to be approximately 5 min in an exbB::Tn10 strain after pulselabelling for 1 min with [ 35 S]methionine, a technique which allows the determination of the chemical half-life of newly synthesized TonB (33) . In our current study, immunoblot analysis revealed that, in an exbB::Tn10 strain, the half-life of TonB at steady state was considerably longer-approximately 30 to 40 min. We repeated the earlier immunoprecipitations, this time making sure to inactivate any endogenous proteases by immediate TCA precipitation after labelling. Our results confirm the previous finding and suggest that TonB exists in two forms: newly synthesized (and rapidly degraded) and in a complex (represented by the slower degradation under steady-state conditions). It has previously been suggested that ExbB and ExbD are required for the assembly of TonB, since cytoplasmically localized TonB missing the first 32 amino acids is also sensitive to their presence or absence (17) .
The initial effect of the absence of ExbB and ExbD may be to largely prevent the assembly of TonB, because of its rapid degradation, presumably in the cytoplasm. The second effect that the absence of ExbB and ExbD may have presumably occurs after the few successfully exported TonB polypeptides have been assembled into a working energy transduction complex in the membrane. It is at this point that ExbB and ExbD have been postulated to recycle TonB, in between rounds of energy transduction (20, 26) .
To quantify the amount of ExbD expressed in the exbB:: Tn10 strain, we determined ExbD-PhoA levels in the presence and absence of the exbB::Tn10 mutation, by both enzymatic and immunoblot assays. Both methods suggested that the exbB::Tn10 mutant was highly polar on exbD expression. exbDphoA expression was reduced to background levels in an exbB::Tn10 mutation. Consistent with those results, exbD-phoA expression was regulated by iron in an exbB ϩ strain with the same pattern previously reported for exbB. Quantitative immunoblot analysis of ExbD-PhoA levels in the presence of the exbB::Tn10 strain showed that the residual ExbD-PhoA expression not detected in the enzymatic assay was constitutive, comprising ϳ20% of the exbB ϩ levels under repressing aerobic conditions and ϳ5% of the exbB ϩ levels under inducing aerobic conditions. Residual exbD transcription could initiate from either the putative exbD promoter or the P out promoter within Tn10. The lack of iron regulation of the residual ExbDPhoA levels was perhaps most consistent with transcription initiation from within the Tn10 element, although to date we have no knowledge of where that residual transcription initiates.
The low level of ExbD expression in exbB::Tn10 strains could formally have accounted entirely for the phenotypes of those strains. To determine the role of ExbB itself in TonBdependent phenomena, we cloned the exbD gene on a multicopy plasmid such that its expression arose from the tet promoter of pZ150 (36) . The native translation initiation region of exbD was maintained by cloning the last 25 codons of exbB preceding exbD in frame with the tetA gene, and the cloned region terminated with the TAA stop codon of exbD. This plasmid, pKP311, complemented an exbD::TnphoA mutant but failed to restore either TonB-dependent function or TonB stability to the exbB::Tn10 exbD::TnphoA double mutant, indicating that loss of ExbB resulted in the same phenotype as loss of ExbD. The complementation data ruled out two other alternatives: first, that the Tn10 insertion in exbB was actually polar on a third gene downstream from exbD, and second, that the effect of the exbD::TnphoA insertion is to prevent expression of ExbB, perhaps by initiating the rapid decay of exb mRNA.
Both ExbB (33) and ExbD (this paper) are required for the stability of chromosomally encoded TonB. Since TonB has been demonstrated to interact physically with ExbB (20, 32) and since TonB and ExbD have similar topologies (12, 15, 29) , we wanted to determine whether TonB-ExbD interactions could be further characterized. Unfortunately, neither in vivo cross-linking nor competition studies with ExbD-PhoA revealed any interactions. Furthermore, the absence of TonB had no effect on the half-life of ExbD-PhoA. Thus, the evidence for such an interaction remains the instability of both newly synthesized and steady-state chromosomally encoded TonB in the absence of ExbD and the requirement of exbD for sensitivities to B-group colicins and bacteriophage 80.
